Form 424B5 ImmunityBio, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
ImmunityBio amends stock sale agreement to authorize $460M offering
December 29, 2025 6:04 AM ESTImmunityBio Inc. (NASDAQ: IBRX) amended its at-the-market stock offering agreement with Jefferies LLC on December 23, authorizing the sale of an additional $459.97 million in common stock shares.
The biotechnology company modified its existing Open Market Sale Agreement from April 2021, which allows for periodic... More
